Sub Banner Image

Novo Falls by Record as Wegovy Slumps and Insider Named CEO

Markets

Naomi Kresge

·

July 29, 2025

·

Bloomberg

Novo Nordisk A/S named its head of international operations as chief executive officer after slumping weight-loss drug sales led to a profit warning that wiped $93 billion off its market value.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.